Takasaki Hirotaka, Kanamori Heiwa, Takabayashi Maki, Yamaji Satoshi, Koharazawa Hideyuki, Taguchi Jun, Fujimaki Katsumichi, Ishigatsubo Yoshiaki
Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Am J Hematol. 2006 Jun;81(6):439-42. doi: 10.1002/ajh.20559.
We report a rare case of a patient with non-Hodgkin's lymphoma who developed multiple bone lesions and hypercalcemia. A 50-year-old woman complained of drowsiness and multiple bone pain on admission. Radiographic examination revealed multiple bone fractures and osteolytic lesions. She was diagnosed with diffuse large B cell lymphoma by biopsy of an inguinal lymph node. Elevation of parathyroid hormone-related protein (PTHrP) and hypercalcemia were confirmed pretreatment, and those serum levels decreased during chemotherapy for lymphoma. However, the disease was resistant to chemotherapy combined with rituximab. These findings suggest that hypercalcemia is associated with PTHrP and the prognosis of patients with bone lymphoma in advanced stage is poor, although it is thought to be a relatively favorable prognosis in localized primary lymphoma of bone.
我们报告了一例罕见的非霍奇金淋巴瘤患者,该患者出现了多处骨病变和高钙血症。一名50岁女性入院时主诉嗜睡和多处骨痛。影像学检查发现多处骨折和溶骨性病变。通过腹股沟淋巴结活检,她被诊断为弥漫性大B细胞淋巴瘤。治疗前证实甲状旁腺激素相关蛋白(PTHrP)升高和高钙血症,在淋巴瘤化疗期间这些血清水平下降。然而,该疾病对联合利妥昔单抗的化疗耐药。这些发现表明,高钙血症与PTHrP有关,晚期骨淋巴瘤患者的预后较差,尽管骨原发性局限性淋巴瘤的预后被认为相对良好。